ABOUT ELITE
PRODUCTS
PIPELINE
- Generic
- Branded
TECHNOLOGY
INVESTOR RELATIONS

HOME | CAREERS | CONTACT | NEWS |

Skip to content

About Elite
Products
Pipeline
- Generic
- Branded
Technology
Investor Relations

Press Releases

Select:

Nov 30, 2006 ELITE TO PRESENT AT BANK OF MONTREAL'S 2006 FOCUS ON HEALTHCARE CONFERENCE ON DECEMBER 7, 2006

Oct 27, 2006 ELITE HOLDS CLINICAL GUIDANCE MEETING WITH THE FDA ON ITS ABUSE DETERRENT PAIN PROGRAM

Sep 12, 2006 Elite Pharmaceuticals Provides Update on Company's Progress and Projected Milestones

Sep 06, 2006 Elite Pharmaceuticals Receives Approval from Independent Review Board to initiate Phase II Clinical Trial for Abuse Resistant Drug Product

Aug 31, 2006 ELITE TO PARTICIPATE IN ROTH CAPITAL'S 2006 NEW YORK CONFERENCE

Aug 16, 2006 Elite Pharmaceuticals is in Compliance with AMEX Requirements

Jun 27, 2006 Elite Pharmaceuticals Successfully Concludes Second Pilot Phase I Trial of its Once-Daily Oxycodone Hydrochloride Product

May 25, 2006 Elite Pharmaceuticals Enters Second Pilot Phase I Trials Of Its Once-Daily Oxycodone Product

Mar 31, 2006 Elite Pharmaceuticals Reviews Key Highlights from Conference Call

Mar 23, 2006 ELITE PHARMACEUTICALS TO HOST CONFERENCE CALL TO REVIEW COMPANY DEVELOPMENTS

22 23 24 25 26 27 28 29 30 31

<< < > >>

Site Map | Privacy | Terms Of Use

Copyright © Elite Pharmaceuticals Inc. | All Rights Reserved.

ART™: Abuse-Resistant Technology for a safer healthier you.

Resize Viewer - Reduce

Resize Viewer - Expand